Biliary Cirrhosis Therapeutic Pipeline Review H2 2014 Report at ReportsnReports.com

Share Article

ReportsnReports.com adds “Biliary Cirrhosis - Pipeline Review, H2 2014” to its store. The report provides an overview of the Biliary Cirrhosis therapeutic pipeline.

Biliary Cirrhosis Therapeutic Pipeline Review

Biliary Cirrhosis Therapeutic Pipeline Review

The report "Biliary Cirrhosis - Pipeline Review, H2 2014" provides comprehensive information on the therapeutic development for Biliary Cirrhosis. Primary biliary cirrhosis is a long-term liver disease in which the bile ducts in the liver become damaged. It is most likely an autoimmune disease, where the body's immune system attacks its own cells. It generally strikes women between the ages of 40 and 60. Symptoms of Primary biliary cirrhosis include the following Fatigue, Pruritus, Right upper quadrant discomfort, Hepatomegaly, Hyperpigmentation, Splenomegaly, Jaundice, Xanthelasmata, Sicca syndrome and Kayser-Fleischer rings. Treatment for primary biliary cirrhosis is difficult, because the immune system appears to be involved. Complete Report is Available @ http://www.reportsnreports.com/reports/322822-biliary-cirrhosis-pipeline-review-h2-2014.html

It also reviews key players involved in the therapeutic development for Biliary Cirrhosis and special features on late-stage and discontinued projects. Companies discussed in this Biliary Cirrhosis Pipeline Review H2 2014 report include AlbireoPharma, Dr. Falk Pharma GmbH, GlaxoSmithKline plc, Intercept Pharmaceuticals, Inc., Johnson & Johnson, MediGene AG, NGM Biopharmaceuticals, Inc., Shire Plc & Virobay Inc.

Drugs profile discussed in this Biliary Cirrhosis Pipeline Review H2 2014 report include A-4250, budesonide, FFP-104, GSK-2330672, Leukothera, NGM-282, obeticholic acid, RhuDex, SHP-625, ustekinumab and VBY-825. Order a Purchase copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=322822 .

Table of Contents

List of Tables
Number of Products under Development for Biliary Cirrhosis, H2 2014 8
Number of Products under Development for Biliary Cirrhosis - Comparative Analysis, H2 2014 9
Number of Products under Development by Companies, H2 2014 10
Comparative Analysis by Late Stage Development, H2 2014 11
Comparative Analysis by Clinical Stage Development, H2 2014 12
Comparative Analysis by Early Stage Development, H2 2014 13
Products under Development by Companies, H2 2014 14
Biliary Cirrhosis - Pipeline by AlbireoPharma, H2 2014 15
Biliary Cirrhosis - Pipeline by Dr. Falk Pharma GmbH, H2 2014 16
Biliary Cirrhosis - Pipeline by GlaxoSmithKline plc, H2 2014 17
Biliary Cirrhosis - Pipeline by Intercept Pharmaceuticals, Inc., H2 2014 18
Biliary Cirrhosis - Pipeline by Johnson & Johnson, H2 2014 19
Biliary Cirrhosis - Pipeline by MediGene AG, H2 2014 20
Biliary Cirrhosis - Pipeline by NGM Biopharmaceuticals, Inc., H2 2014 21
Biliary Cirrhosis - Pipeline by Shire Plc, H2 2014 22
Biliary Cirrhosis - Pipeline by Virobay Inc., H2 2014 23
Assessment by Monotherapy Products, H2 2014 24
Number of Products by Stage and Target, H2 2014 26
Number of Products by Stage and Mechanism of Action, H2 2014 28
Number of Products by Stage and Route of Administration, H2 2014 30
Number of Products by Stage and Molecule Type, H2 2014 32
Biliary Cirrhosis Therapeutics - Recent Pipeline Updates, H2 2014 51
Biliary Cirrhosis - Dormant Projects, H2 2014 62

List of Figures
Number of Products under Development for Biliary Cirrhosis, H2 2014 8
Number of Products under Development for Biliary Cirrhosis - Comparative Analysis, H2 2014 9
Number of Products under Development by Companies, H2 2014 10
Comparative Analysis by Clinical Stage Development, H2 2014 12
Assessment by Monotherapy Products, H2 2014 24
Number of Products by Top 10 Targets, H2 2014 25
Number of Products by Stage and Top 10 Targets, H2 2014 25
Number of Products by Top 10 Mechanism of Actions, H2 2014 27
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 27
Number of Products by Top 10 Routes of Administration, H2 2014 29
Number of Products by Stage and Top 10 Routes of Administration, H2 2014 29
Number of Products by Top 10 Molecule Types, H2 2014 31
Number of Products by Stage and Top 10 Molecule Types, H2 2014 31

Explore more reports on Pharmaceuticals industry at http://www.reportsnreports.com/market-research/pharmaceuticals/ .

About Us:
ReportsnReports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
ReportsnReports
+1 (888) 391-5441
Email >
@LifeSciReports
Follow >
Sandler Research
since: 04/2014
Like >
Follow us on
Visit website